Superpower Secures $42 Million Investment From Forerunner Ventures And Others For Peptide Market Expansion

Superpower, a San Francisco-based health platform, has raised $42 million to date as it expands into the fast-growing but loosely regulated peptide market, building on its 2023 launch offering biomarker testing and AI-driven health guidance. Led by cofounder and CEO Max Marchione, the company is now selling legally available peptides to its members and plans to develop proprietary products while funding clinical trials and advocating for broader regulatory approval. Its strategy comes amid shifting policy signals from Robert F. Kennedy Jr. regarding peptide restrictions, as well as rising consumer demand despite limited clinical evidence, positioning Superpower to compete with other telehealth and longevity players in a market projected to grow significantly in the coming years.

FOUNDER: Max Marchione

INVESTORS: Forerunner Ventures, Susa Ventures, Winklevoss Capital, Vanessa Hudgens, Logan Paul & Giannis Antetokounmpo

AMOUNT: $42,000,000

HQ: San Francisco, California

#VentureCapital #Superpower #MaxMarchione #TradedVC